Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep:104:148-157.
doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.

Buprenorphine in the United States: Motives for abuse, misuse, and diversion

Affiliations
Free article
Review

Buprenorphine in the United States: Motives for abuse, misuse, and diversion

Howard D Chilcoat et al. J Subst Abuse Treat. 2019 Sep.
Free article

Abstract

Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD.

Keywords: Access to care; Buprenorphine; Health policy; Opioid abuse; Self-treatment.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources